Alembic Pharmaceuticals gets FDA final approval for Ketorolac Tromethamine
Alembic Pharmaceuticals has secured final approval for its abbreviated new drug application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 mL (30 mg/mL) Single Dose Vials from the US Food and Drug Administration (FDA). The product is the generic version of Roche’s Toradol Injection, 15 mg/mL, 30 mg/mL, and 60 […]